Randomised study of switch toDTG/RPV in subjects with HIV RNA <50c/ml and archived K103N over 48 weeks
Por:
Moyle, G, Assoumou, L, Molina, J, Post, F, Curran, A, Rusconi, S, De Wit, S, Stephan, C, Raffi, F, Johnson, M, Masia, M, Vera, J, Morris, K, Duffy, A, Fletcher, C and Pozniak, A
Publicada:
1 ago 2022
Resumen:
Filiaciones:
Moyle, G:
Chelsea & Westminster Hosp, HIV, London, England
Assoumou, L:
Univ Paris 06, Sorbonne Univ, UPMC,ANRS, INSERM,Pierre Louis Inst Epidemiol & Publ Hlth,UM, Paris, France
Molina, J:
Hosp St Louis, Paris, France
Post, F:
Kings Coll NHS Fdn Trust, London, England
Curran, A:
Hosp Univ Vall dHebron, Barcelona, Spain
Rusconi, S:
Univ Milan, Dept Biomed & Clin Sci Luigi Sacco ASST, Milan, Italy
De Wit, S:
Univ Hosp St Pierre, Brussels, Belgium
Stephan, C:
Goethe Univ Frankfurt, Frankfurt, Germany
Raffi, F:
Univ Hosp Nantes, Hop Hotel Dieu, Serv Infectiol, Nantes, France
Johnson, M:
Royal Free London NHS Fdn Trust, London, England
:
Gen Univ Hosp Elche, Infect Dis Unit, Elche, Spain
Vera, J:
Brighton & Sussex Univ Hosp, Elton John Ctr, Brighton, E Sussex, England
Morris, K:
Res Org Kings Cross, London, England
Duffy, A:
Res Org Kings Cross, London, England
Fletcher, C:
Res Org Kings Cross, London, England
Pozniak, A:
Chelsea & Westminster NHS Fdn Trust, London, England
|